| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.0B | $1.0B | $-1.6B | $1.7B | $2.4B | $-0.9B | $-2.2B | $0.1B |
| EPS (Basic) | $2.92 | $1.62 | $-3.61 | $3.93 | $1.60 | $-0.73 | $0.82 | $-1.74 |
| EPS (Diluted) | $2.92 | $1.62 | $-3.61 | $3.92 | $1.60 | $-0.73 | $0.82 | $-1.74 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $135.6B | $103.6B | $93.2B | $81.9B | $76.8B | $88.5B | $130.3B | $105.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | $1.4B | $1.6B | $1.3B | $1.2B | $1.9B | $1.7B |
| Total Liabilities | $119.4B | $90.9B | $81.9B | $70.5B | $63.6B | $74.4B | $114.5B | $91.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $16.1B | $12.6B | $11.3B | $11.3B | $13.2B | $14.0B | $15.8B | $14.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $3.3B | $2.4B | $5.4B | $3.1B | $0.5B | $-1.2B | $2.6B |
| Investing Cash Flow | $-27.4B | $-15.0B | $-8.4B | $-14.5B | $4.9B | $40.4B | $-20.6B | $-0.9B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $27.2B | $11.8B | $5.9B | $9.4B | $-7.9B | $-41.5B | $22.0B | $-0.7B |